113
Views
10
CrossRef citations to date
0
Altmetric
Special Report

Maternal immunization to protect the mother and neonate

Pages 813-818 | Published online: 09 Jan 2014

References

  • Glezen WP. Maternal vaccines. primary care. Clin. Office Pract. 28, 791–806 (2001).
  • Glezen WP. Effect of maternal antibodies on the infant immune response vaccine. Vaccine 21, 3389–3392 (2003).
  • Dancis J, Lind J, Oratz J et al. Placental transfer of proteins in human gestation. Am. J. Obstet. Gynecol. 82, 167–171 (1961).
  • Bright NA, Ockleford CD. Cytotrophoblast cells: a barrier to maternal fetal transmission of immunity. J. Histochem. Cytochem. 43, 933–944 (1995).
  • Gusdon JP. Fetal and maternal immuno-globulin levels during pregnancy. Am. J. Obstet. Gynecol. 103, 895–900 (1969).
  • Garty BZ, Ludomirsky A, Danon YL et al. Placental transfer of immunoglobulin G subclasses. Clin. Diagn. Lab. Immunol. 1, 667–669 (1994).
  • Malek A, Sager R, Kuhn P et al. Evaluation of maternofetal transport of immunoglobulin during human pregnancy. Am. J. Reprod. Immunol. 36, 248–255 (1996).
  • Malek A, Sager R, Schneider H. Maternal–fetal transport of immunoglobulin G and its subclasses during the third trimester of pregnancy. Am. J. Reprod. Immunol. 32, 8–14 (1994).
  • Kohler PF, Farr RS. Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental transport. Nature 210(40), 1071–1071 (1996).
  • Thompson WW, Shag DK, Stephenson T et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. JAMA 289, 179–186 (2003).
  • Swing WL, James DK, Stepehenson T et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. Br. J. Obstet. Gynecol. 107, 1282–1289 (2000).
  • Griffiths PD, Ronalds CJ, Heath RB. A prospective study of influenza infection in pregnancy. J. Epidemiol. Community Health 34, 124–128 (1980).
  • Hardy JM, Azarowicz EN, Mannini A et al. The effect of Asian Influenza on the outcome of pregnancy, Baltimore 1957–1958. Am. J. Public Health 51, 1182–1188 (1961).
  • Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 72, 978–980 (1919).
  • Neuzil JM, Reed GW, Mitchell EF et al. Impact of influenza on acute cardio-pulmonary hospitalizations in pregnant women. Am. J. Epidemiol. 148, 1094–1102 (1998).
  • Heinonen OP, Shapiro S, Morrison RR et al. Immunization during pregnancy against polio and influenza in relation to childhood malignancy. Int. J. Epidemiol. 2, 229–235 (1973).
  • Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine. Reactogenicity and immunogenicity in mother and infant. J. Infect. Dis. 140, 141–146 (1979).
  • Murray DL, Imagawa DT, Okada DM et al. Antibody response to monovalent a/new jersey/8/76 influenza vaccine in pregnant women. J. Clin. Microbiol. 10, 184–187 (1979).
  • Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB, Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 53(RR-6), 1–40 (2004).
  • Glezen WP, Taber LH, Frank AL et al. Influenza infections in infants. Pediatr. Infect. Dis. J. 16, 1065–1068 (1997).
  • Puck JM, Glezen WP, Frank AL et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis. 142, 844–840 (1980).
  • Reunan PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother–infant pairs. Pediatr. Infect. Dis. J. 6, 398–403 (1987).
  • Buck RD, H-Wang LY, Ho EYF et al. Outcome of perinatal hepatitis B exposure is dependent on maternal viral load. J. Infect. Dis. 170, 14–18 (1994).
  • Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Hepatitis B virus infection: a comprehensive immunization strategy to eliminate transmission in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. (In press) (2005).
  • Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC; Centers for Disease Control and Prevention. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Recomm. Rep. 51(RR-2), 1–35 (2002).
  • Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the united states through universal childhood vaccination. Recommendations of the Advisory Committee for Immunization Practice (ACIP). MMWR Recomm. Rep. 40(RR-13), 1–25 (1991).
  • American Academy of Pediatrics, Committee on Infectious Disease. Hepatitis B. In: 2003 Red Book: Report on the Committee on Infectious Diseases. 26th Ed. Pickering LK (Ed). American Academy of Pediatrics, Elk Grove Village, IL, USA, 318–336 (2003).
  • Ingardia CJ, Kelley L, Steinfeld JD et al. Hepatitis B vaccination in pregnancy: factors influencing efficacy. Obstet. Gynecol. 93, 983–986 (1999).
  • Ingardia CJ, Kelley L, Lerer T et al. Correlation of maternal and fetal hepatitis B antibody titers following maternal vaccination in pregnancy. Am. J. Perinatol. 16, 129–132 (1999).
  • Centers for Disease Control. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm. Rep. 40(RR-10) 1–28 (1991).
  • England JA, Mbawuike IN, Hammill H et al. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J. Infect. Dis. 168, 647–656 (1993).
  • Cherry J.D. The epidemiology of pertusis immunization in the United Kingdom and in the United States. A comparative study. Curr. Probl. Pediatr. 14, 1–78 (1984).
  • Centers for Disease Control. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 46(RR-7), 1–25 (1997).
  • Centers for Disease Control. Pertussis Surveillance United States, 1989–1991. MMWR CDC Surveill. Summ. 41(55–8), 11–19 (1992).
  • Halperin S, Smith B, Russell M et al. Adult formulation of a component acellular pertussis vaccine combined with diphtheria and tetanus toxoid and inactivated poliovirus is safe and immunogenic in adolescents and adults. Pediatr. Infect. Dis. J. 19, 276–284 (2000).
  • Black S. Epidemiology of pertussis. Pediatr. Infect. Dis. J. 16, 85–89 (1997).
  • Wortis N, Strebel PM, Wharton M et al. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics 97, 607–612 (1996).
  • Izurieta HS, Kenyon TA, Strebel PM et al. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin. Infect. Dis. 22, 503–507 (1996).
  • Centers for Disease Control. Pertussis – United States, 1997 to 2000. Age distribution and incidence of reported cases. MMWR Morb. Mortal. Wkly Rep. 51, 74–76 (2002).
  • Pichichero ME, Rennels MB, Edwards KM et al. Combined tetanus, diptheria and 5 component pertussis vaccine for use in adolescents and adults. JAMA 293, 3003–3011(2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.